Patents by Inventor Erika Yoshida

Erika Yoshida has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Host cells and methods for producing hydroxytyrosol
    Patent number: 11932896
    Abstract: The present invention provides for a composition comprising: (a) a first host cell capable of producing L-DOPA; and (b) a modified host cell is capable of converting L-DOPA into hydroxytyrosol (HTy); wherein any one or both of the first host cell and second host cell is a genetically modified host cell.
    Type: Grant
    Filed: December 26, 2018
    Date of Patent: March 19, 2024
    Assignee: The Regents of the University of California
    Inventors: Erika Yoshida, Taek Soon Lee
  • Method for producing a protein and disaccharide using a
    Patent number: 11384379
    Abstract: A method for producing an objective protein and a method for producing a disaccharide are provided. An objective protein is produced by culturing Talaromyces cellulolyticus in a culture medium containing an expression inducer such as gentiobiose. A disaccharide is produced from a saccharide raw material by enzymatic conversion using a disaccharide synthesizing enzyme.
    Type: Grant
    Filed: March 23, 2020
    Date of Patent: July 12, 2022
    Assignee: AJINOMOTO CO., INC.
    Inventors: Daiki Yahagi, Erika Yoshida, Hiroaki Fukada, Mitsunori Tokura, Uno Tagami, Masayuki Sugiki
  • Protein Production Method and Disaccharide Production Method
    Publication number: 20200263219
    Abstract: A method for producing an objective protein and a method for producing a disaccharide are provided. An objective protein is produced by culturing Talaromyces cellulolyticus in a culture medium containing an expression inducer such as gentiobiose. A disaccharide is produced from a saccharide raw material by enzymatic conversion using a disaccharide synthesizing enzyme.
    Type: Application
    Filed: March 23, 2020
    Publication date: August 20, 2020
    Applicant: AJINOMOTO CO., INC.
    Inventors: Daiki Yahagi, Erika Yoshida, Hiroaki Fukada, Mitsunori Tokura, Uno Tagami, Masayuki Sugiki
  • HOST CELLS AND METHODS FOR PRODUCING HYDROXYTYROSOL
    Publication number: 20190194698
    Abstract: The present invention provides for a composition comprising: (a) a first host cell capable of producing L-DOPA; and (b) a modified host cell is capable of converting L-DOPA into hydroxytyrosol (HTy); wherein any one or both of the first host cell and second host cell is a genetically modified host cell.
    Type: Application
    Filed: December 26, 2018
    Publication date: June 27, 2019
    Applicant: The Regents of the University of California
    Inventors: Erika Yoshida, Taek Soon Lee
  • Pharmaceutical composition comprising a tricyclic compound for the prevention or treatment of skin diseases
    Publication number: 20040220204
    Abstract: To provide a pharmaceutical composition comprising a tricyclic compound (I) or its pharmaceutically acceptable salt; monohydric alcohol fatty acid esters; dibasic acid diesters; lower alkylene carbonates; butylene glycol; diethylene glycol mono(lower)alkyl ethers; and thickeners. It is satisfactory in stability and absorption kinetics and/or a low irritation potential.
    Type: Application
    Filed: May 20, 2004
    Publication date: November 4, 2004
    Inventors: Satoshi Ueda, Toshiro Sakai, Erika Yoshida
  • Medicinal compositions
    Patent number: 6673808
    Abstract: To provide a pharmaceutical composition comprising a macrolide compound, such as tricyclic compound (I) or its pharmaceutically acceptable salt, a dissolution/absorption promoter, a pharmaceutical base, and optionally a compatibilizing agent and/or a thickener. It is satisfactory in stability and absorption kinetics and/or a low irritation potential.
    Type: Grant
    Filed: November 22, 2000
    Date of Patent: January 6, 2004
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Rinta Ibuki, Fumio Shimojo, Satoshi Ueda, Toshihiko Toyoda, Masayuki Yamanaka, Erika Yoshida
  • Medicinal compositions
    Patent number: 6586444
    Abstract: To provide a pharmaceutical composition comprising a macrolide compound, such as tricyclic compound (I) or its pharmaceutically acceptable salt, a dissolution/absorption promoter, a pharmaceutical base, and optionally a compatibilizing agent and/or a thickener. It is satisfactory in stability and absorption kinetics and/or a low irritation potential.
    Type: Grant
    Filed: December 7, 2001
    Date of Patent: July 1, 2003
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Rinta Ibuki, Fumio Shimojo, Satoshi Ueda, Toshihiko Toyoda, Masayuki Yamanaka, Erika Yoshida
  • Medicinal compositions
    Publication number: 20020061907
    Abstract: To provide a pharmaceutical composition comprising a macrolide compound, such as tricyclic compound (I) or its pharmaceutically acceptable salt, a dissolution/absorption promoter, a pharmaceutical base, and optionally a compatibilizing agent and/or a thickener. It is satisfactory in stability and absorption kinetics and/or a low irritation potential.
    Type: Application
    Filed: December 7, 2001
    Publication date: May 23, 2002
    Applicant: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Rinta Ibuki, Fumio Shimojo, Satoshi Ueda, Toshihiko Toyoda, Masayuki Yamanaka, Erika Yoshida